lifestyle.newsblaze.com

Author: RenovoRx, Inc.

RenovoRx Establishes RenovoCath® Medical Advisory Board

February 12, 2026
RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer

February 11, 2026
RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting

February 10, 2026
RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center

January 20, 2026